The efficacy of low level laser therapy in preventing radiation dermatitis

The efficacy of low level laser therapy in preventing radiation dermatitis: clinical feasibility evaluation

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0002706

Enrollment

Registered

2018-02-23

Start date

2017-09-07

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : Low level laser therapy (LLLT) - LLLT will be performed to neck and supraclavicular are during radiation therapy. on Monday, Wednesday, Friday. using HealLite II (Lutronic, Korea)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Head and neck and Lung cancer patients who will receive curative RT of 60 Gy or more a) patients who receive radiation therapy with curative aim b) 60 Gy (BED 72 Gy10, aß=10) or more radiation therapy to neck or supraclavicular area. BED10=daily dose x number of fractions x (1+dailiy dose/aß) (aß=10) c) ECOG 0-1

Exclusion criteria

Exclusion criteria: a) pregnancy b) a history of photosensitivity

Design outcomes

Primary

Measure	Time frame
The most severe grade of radiation dermatits (CTCAE 4.0 grade)	—

Secondary

Measure	Time frame
compliance of LLLT (treated number of LLLT/ planned number of LLLT);LLLT toxicity	—

Countries

Korea, Republic of

Contacts

Public ContactDongryul Oh

Samsung Medical Center

dongryul.oh@samsung.com+82-2-6007-5439

Outcome results